Opposite effects of estrogen and the progestin R5020 on cell proliferation and GCDFP-15 expression in ZR-75-1 human breast cancer cells. [electronic resource]
- Molecular and cellular endocrinology Oct 1990
- 171-8 p. digital
Publication Type: Journal Article
0303-7207
10.1016/0303-7207(90)90130-z doi
Apolipoproteins Apolipoproteins D Breast Neoplasms--pathology Carrier Proteins Cell Division--drug effects Drug Interactions Estradiol--pharmacology Flutamide--analogs & derivatives Gene Expression Regulation, Neoplastic--drug effects Glycoproteins Humans Membrane Transport Proteins Mifepristone--pharmacology Neoplasm Proteins--biosynthesis Promegestone--pharmacology Tumor Cells, Cultured--drug effects